Organized Self-Management Support Services for Chronic Depression

Depression Clinical Trial

— Stride  

Official title:

Organized Self-Management Support Services for Chronic Depression

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01139060
• Other study ID #: 5R01MH082995
• Status: Completed
• Phase: Phase 3
• First received: June 4, 2010
• Last updated: October 11, 2017
• Start date: August 2009

Study information

• Verified date: October 2017
• Source: Kaiser Permanente
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose is to test the effectiveness of an organized care program for chronic or recurrent depression. Using a two-arm design, the investigators will randomly assign 300 participants with chronic or recurrent depression to one of two conditions: continued usual care (UC); or an 18-month organized treatment program focused on outreach and engagement, including a weekly group self-management training program, monthly visits with a psychotherapist (in-person or by telephone), and optional one-on-one visits with a peer support specialist. All intervention components are intended as adjuncts to any existing depression treatment (usually antidepressant medication) provided by participants' regular providers.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 302
• Est. primary completion date: April 2013
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• all patients will meet criteria for recurrent major depression or dysthymia

Exclusion Criteria:

• bipolar disorder or psychotic disorder

Related Conditions & MeSH terms

• Depression
• Depressive Disorder

Intervention

Behavioral:
• organized care program for chronic or recurrent depression

Locations

Country	Name	City	State
United States	Group Health Research Insitute	Seattle	Washington
United States	Swedish Cherry Hill Clinic	Seattle	Washington

Sponsors (2)

Lead Sponsor	Collaborator
Kaiser Permanente	Swedish Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Evaluate the program's effectiveness, i.e., the effects of the intervention on patient outcomes (depressive symptoms, functional impairment, and disability/lost productivity) and process of care (self-efficacy and self-management behaviors)		18 months
Secondary	Examination of moderators of treatment response		18 months
Secondary	An estimate of the program's costs and effect on the costs of treatment for depression		18 months